Investopedia … or $0.02 per share, to $10.5 million, or $0.08 per share. What was to blame for the sizable increase in its net loss? Primarily it was a huge gain experienced in 2014 from the revaluation of warrants. … Additionally, Galena shored up its balance … Stock Update (NASDAQ:GALE): Galena Biopharma Inc Reports First Quarter …Smarter Analyst |
![](https://i0.wp.com/commonstockwarrants.com/wp-content/uploads/2015/05/140137-thumb.jpg?fit=80%2C80&ssl=1)